|
Volumn 24, Issue 4, 1997, Pages 440-454
|
Chemotherapy for advanced non-small cell lung cancer: Past, present, and future
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTISENSE OLIGODEOXYNUCLEOTIDE;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
EDATREXATE;
ETOPOSIDE;
FOLINIC ACID;
GEMCITABINE;
GRANULOCYTE COLONY STIMULATING FACTOR;
IFOSFAMIDE;
IRINOTECAN;
METHOTREXATE;
MITOMYCIN C;
MONOCLONAL ANTIBODY;
NAVELBINE;
PACLITAXEL;
PROCARBAZINE;
VINBLASTINE;
VINDESINE;
ADVANCED CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
DIARRHEA;
DRUG EFFICACY;
GENE THERAPY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKOPENIA;
LUNG NON SMALL CELL CANCER;
META ANALYSIS;
MOLECULAR BIOLOGY;
NAUSEA;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
REVIEW;
VOMITING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
HUMANS;
LUNG NEOPLASMS;
PACLITAXEL;
TAXOIDS;
VINBLASTINE;
|
EID: 0030787505
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (53)
|
References (132)
|